Patent details

EP3697386 Title: LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTS

Basic Information

Publication number:
EP3697386
PCT Application Number:
US2018056721
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP188688014
PCT Publication Number:
WO2019079726
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTS
French Title of Invention:
COMPOSITIONS LIQUIDES POUR L'USAGE PÉRORAL COMPRENNANT DÉRIVÉS DE PHOSPHATIDYLGLYCEROL ET EXCIPIENTS THIXOTROPIQUES POUR LE TRAITEMENT DE CANALOPATIES CARDIAQUES CAUSEÉS PAR AGENTS PHARMACOLOGIQUES
German Title of Invention:
FLÜSSIGE ZUSAMMENSETZUNGEN ZUR PERORALEN VERWENDUNG UMFASSEND PHOSPHATIDYLGLYCEROL DERIVATE UND THIXOTROPISCHE HILFSSTOFFE ZUR BEHANDLUNG VON HERZKANALOPATHIEN VERURSACHT DURCH PHARMAKOLOGISCHE WIRKSTOFFE
SPC Number:

Dates

Filing date:
19/10/2018
Grant date:
26/07/2023
EP Publication Date:
26/08/2020
PCT Publication Date:
25/04/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/07/2023
EP B1 Publication Date:
26/07/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/10/2023
Expiration date:
19/10/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/07/2023
 
 

Name:
Signpath Pharma, Inc.
Address:
9710 Ruskin Circle, Sandy, UT 84092, United States (US)

Inventor

1

Name:
HELSON, Lawrence
Address:
United States (US)

2

Name:
BOUCHARD, Annie
Address:
Canada (CA)

3

Name:
MAJEED, Muhammed
Address:
United States (US)

4

Name:
SHOPP, George, M.
Address:
United States (US)

Priority

Priority Number:
201715788683
Priority Date:
19/10/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/127; A61K 9/00; A61K 31/506; A61K 31/683; A61K 31/685; A61K 31/445; A61K 31/12; A61K 31/4545; A61P 9/00; A61P 9/02; A61P 9/04; A61P 9/06; A61P 35/00; A61P 37/08;

Publication

European Patent Bulletin

Issue number:
202330
Publication date:
26/07/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages